Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Qatar.
Campus
Campus

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
How does Dupixent support lung function improvement in Pediatric Asthma?

How does Dupixent support lung function improvement in Pediatric Asthma?

Learn more
No Rebound Effect Post Clopidogrel Withdrawal

No Rebound Effect Post Clopidogrel Withdrawal

Learn more
Insights and impacts from the TALOS-AMI Trial

Insights and impacts from the TALOS-AMI Trial

Learn more
How does Dupixent improve Asthma control and quality of live for Pediatric Patients?

How does Dupixent improve Asthma control and quality of live for Pediatric Patients?

Learn more
Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

Learn more
Statin/ezetimibe SPC for better adherence to LLT

Statin/ezetimibe SPC for better adherence to LLT

Learn more
The reason for MS – beyond focal inflammation

The reason for MS – beyond focal inflammation

Learn more
There is significant unmet need in the management of PN¹

There is significant unmet need in the management of PN¹

Learn more
Statin/Ezetimibe Combination VS Statin Monotherapy

Statin/Ezetimibe Combination VS Statin Monotherapy

Learn more
Single-Pill Combinations in Dyslipidemia

Single-Pill Combinations in Dyslipidemia

This review describes the potential benefits of combination treatment and presents data supporting the use of single-pill combination (SPC) for increasing exposure to lipid-lowering treatment (LLT).

Learn more
Exploring the risk for severe hypoglycemia in the pool of studied patients with T1D

Exploring the risk for severe hypoglycemia in the pool of studied patients with T1D

Learn more
Should we encourage earlier and broader use of combination therapies in dyslipidemia?

Should we encourage earlier and broader use of combination therapies in dyslipidemia?

Learn more